Kidney-Failure
发表于 2025-3-25 07:17:02
http://reply.papertrans.cn/17/1602/160168/160168_21.png
锡箔纸
发表于 2025-3-25 08:05:16
http://reply.papertrans.cn/17/1602/160168/160168_22.png
LASH
发表于 2025-3-25 15:32:23
Derivation of Mathematical Models,bability for observing a sufficient magnitude of response rate at the end of enriched enrollment phase given the observed data at an interim look. The method is applied to derive futility stopping rules, and the sensitivity of the futility stopping rules is examined based upon the choice of prior di
penance
发表于 2025-3-25 18:58:06
http://reply.papertrans.cn/17/1602/160168/160168_24.png
咯咯笑
发表于 2025-3-25 20:06:18
Enzyme Kinetics of PAPS-Sulfotransferasernative hypotheses for both plausible endpoints. Here, we explore characteristics of the design when the alternative hypothesis for only one of the two endpoints is true, and the treatment effect for another endpoint is null (an extremely worst case) or lower than what was anticipated per trial desi
PAD416
发表于 2025-3-26 02:57:27
Jaydeep Yadav,Ken Korzekwa,Swati Nagarility of study success (PrSS) or probability of success (POS). We discuss the important role that PrSS can play in clinical trial design and decision making throughout medical product development. A few examples are given for illustration.
inveigh
发表于 2025-3-26 08:08:25
http://reply.papertrans.cn/17/1602/160168/160168_27.png
帐单
发表于 2025-3-26 11:58:15
http://reply.papertrans.cn/17/1602/160168/160168_28.png
nugatory
发表于 2025-3-26 16:29:38
http://reply.papertrans.cn/17/1602/160168/160168_29.png
cardiopulmonary
发表于 2025-3-26 17:32:30
http://reply.papertrans.cn/17/1602/160168/160168_30.png